期刊文献+

苦参碱对人肺腺癌A549细胞增殖及HIF-1α、VEGF表达的影响 被引量:16

Effect of matrine on proliferation and HIF-1α,VEGF expression of A549 cells
下载PDF
导出
摘要 目的探讨苦参碱对人肺腺癌A549细胞增殖的影响及作用机制。方法将0、5、50、100、250、500μg/mL质量浓度的苦参碱分别作用于体外培养的处于对数生长期的A549细胞,MTT法检测细胞生长抑制率,RT-PCR法检测细胞缺氧诱导因子-1α(HIF-1α)mRNA和血管内皮生长因子(VEGF)mRNA表达。结果苦参碱呈时间、剂量依赖性抑制A549细胞生长(P<0.05);呈时间、剂量依赖性降低HIF-1α、VEGF mRNA表达(P<0.05);HIF-1α和VEGF之间表达呈正相关(r=0.994,P<0.01)。结论苦参碱能抑制人肺腺癌A549细胞的增殖,其机制可能为降低HIF-1α和VEGF表达,从而抑制肺癌组织血管生成。 Objective To explore the effect and mechanism of matrine on the proliferation of A549 cells. Methods A549 cell line in logarithmic growth cultured in vitro was treated by matrine with the concentration of 0, 5, 50, 100,250, 500 μg/mL, respectively, and then cellular proliferation was evaluated by MTT method. Hypoxia-inducible factor-1 α( HIF- 1 α )and vascular endothelial growth factor (VEGF) mRNA expression in A549 cells were detected by RT-PCR analysis. Results Matrine inhibited the proliferation of A549 cells in a dose and time-dependent manner( P 〈 0.05 ) ; inhibited the expression of HIF-1α, VEGF mRNA in a close and time-dependent (P 〈 0. 05 ) ; there was a positive correlation between the expression of HIF-1α mRNA and VEGF mRNA( r = 0. 994 ,P 〈 0. 01 ). Conciusion Matrine can inhibit the proliferation of A549 cel1 line, the mechanism may down-regulate the expression of HIF-1α and VEGF, so to inhibit the vascular growth of lung cancer tissue.
出处 《山东医药》 CAS 2012年第3期25-27,共3页 Shandong Medical Journal
基金 南通市社会发展科技计划资助项目(S2009061)
关键词 苦参碱 肺肿瘤 缺氧诱导因子-1Α 血管内皮生长因子 matrine lung tumor hypoxia-inducible factor-1 α vascular endothelial growth factor
  • 相关文献

参考文献10

  • 1颉玉欣,李国慧,张牧霞.苦参碱抗肿瘤及引起肿瘤细胞凋亡的研究进展[J].河北医药,2008,30(12):1972-1973. 被引量:6
  • 2李丹.苦参碱的研究进展[J].咸宁学院学报(医学版),2007,21(5):458-460. 被引量:17
  • 3Herodin F, Bourin P, Mayol JE. Short-term injection of anti-apoptotic cytokine combinations soon after lethal-irradiationpromotes survival[ J ]. Blood, 2003,101 ( 7 ) :2609-2616.
  • 4Israels ED, Israels LG. The cell cycle[J]. Stem Cell, 2001,19 ( 1 ) :88-91. Li J, Sail MW. Current use and potential role of bevaeizumab in the.
  • 5Israels ED, Israels LG. The cell cycle[J]. Stem Cell, 2001,19 ( 1 ) :88-91. Li J, Sail MW. Current use and potential role of bevaeizumab in thetreatment of gastrointestinal cancers [ J].Biologics, 2009, ( 3 ) :429-441.
  • 6Inoue K, Kamada M, Slaton JW, et al. The prognostic value ofangiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter[ J ]. Clin Cancer Res, 2002,8(6) :1863-1870.
  • 7Yasuda S, Arii S, Moil A, et al. Hexokinase U and VEGF expression in liver tumors:correlation with hypoxia-inducible factorl alpha and its significance[ J]. J Hepatol, 2004,40( l ) : 117-123.
  • 8Mabjeesh NJ, Amir S. Hypoxia-inducible factor(HIF) in human tumorigenesis [ J 1. Histol Histopathol, 2007,22 ( 5 ) :559-572.
  • 9Roskoski R. Jr: Vascular endothelial growth factor ( VEGF ) signaling in tumor progression [ J]. Crit Rev Oncol Hematol, 2007,62 (3) :179-213.
  • 10Duffy JP, Eibl G, Reber HA, et al. Influence ofhypoxia and neo angiogenesis on the growth of pancreatic cancer[ J]. Mol Cancer, 2003,2(2) :12.

二级参考文献46

共引文献20

同被引文献268

引证文献16

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部